Breast cancer risk: Perception versus reality

Contraception

Volumn 59, Issue 1 SUPPL., 1999, Pages 25S-28S

  Westhoff, Carolyn L ^a  

^a Columbia Univ Coll Phys Surgs ^*  (United States)

Author keywords

Breast cancer risk; Epidemiology; Oral contraceptives; Recency effects

Indexed keywords

ESTROGEN; GESTAGEN; ORAL CONTRACEPTIVE AGENT;

ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RISK; DOSE RESPONSE; FEMALE; HORMONAL CONTRACEPTION; HUMAN; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION;

EID: 0033009022     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(98)00134-6     Document Type: Article

References (11)

1. Cancer Facts and Figures. 1997;8-9 American Cancer Society, Atlanta.
2. Black W.C., Nease R.F. Jr, Tosteson A.N.A. Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst. 87:1995;720-731.
3. US Bureau of the Census. Statistical abstract of the United States:1996, 115th ed. Washington, DC,1996.
4. Attitudes Toward Contraception. 1985;Princeton, New Jersey.
5. Gallup Organization. Women's Attitudes Toward Oral Contraceptives and Other Forms of Birth Control. Princeton, New Jersey: 1994.
6. Schlesselman J.J. Cancer of the breast and reproductive tract in relation to use of oral contraceptives. Contraception. 40:1989;1-38.
7. Breast cancer and hormonal contraceptives collaborative breast cancer reanalysis of individual data on 53 297 women with and 100 239 women without breast cancer from 54 epidemiological studies . Lancet. 347:1996;1713-1727.
8. Breast cancer and hormonal contraceptives further results . Contraception. 54:1996;1S-106S.
9. Bernstein L., Ross R.K., Henderson B.E. Relationship of hormone use to cancer risk. J Natl Cancer Inst Monogr. 12:1992;137-147.
10. Yuen J., Persson I., Bergkvist L., et al. Hormone replacement therapy and breast cancer mortality in Swedish women results after adjustment for 'healthy drug user' effect . Cancer Causes Control. 4:1993;369-374.
11. Ettinger B., Friedman G.D., Bush T., Quesenberry C.P. Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol. 87:1996;6-12.